These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7260219)

  • 1. Persistent amphetamine-induced compulsive rituals: response to pyridoxine(B6).
    Frye PE; Arnold LE
    Biol Psychiatry; 1981 Jun; 16(6):583-7. PubMed ID: 7260219
    [No Abstract]   [Full Text] [Related]  

  • 2. Bupropion and compulsive behavior.
    Jacobsen LK; Chappell P; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):143-4. PubMed ID: 8138514
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive-compulsive symptoms following stimulants.
    Koizumi HM
    Biol Psychiatry; 1985 Dec; 20(12):1332-3. PubMed ID: 4063424
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interview with Dr. Roland Härtel, Beiruth. "Compulsive hunt for pimples": how you can recognize crystal dependent patients (interview by Dr. Elke Oberhofer)].
    Härtel-Petri R; Oberhofer E
    MMW Fortschr Med; 2014 Aug; 156(14):20. PubMed ID: 25195389
    [No Abstract]   [Full Text] [Related]  

  • 6. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparison of the stereotyped behavior-inducing effects of d- and l-amphetamine in dogs.
    Wallach MB; Angrist BM; Gershon S
    Commun Behav Biol; 1971 Aug; 6(2):93-6. PubMed ID: 5167405
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituals, stereotypy and compulsive behavior in animals and humans.
    Eilam D; Zor R; Szechtman H; Hermesh H
    Neurosci Biobehav Rev; 2006; 30(4):456-71. PubMed ID: 16253329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE; Thompson PD; Kiley MA
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compulsive behavior in Prader-Willi syndrome: examining severity in early childhood.
    Dimitropoulos A; Blackford J; Walden T; Thompson T
    Res Dev Disabil; 2006; 27(2):190-202. PubMed ID: 15950435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
    Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Rak D; Perovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T; Boban-Blagaic A; Bedekovic V; Tonkic A; Babic S
    Acta Pharmacol Sin; 2002 May; 23(5):412-22. PubMed ID: 11978191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on: "Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats." Psychopharmacologia (1967) 10:316-323.
    Cools AR
    Psychopharmacology (Berl); 2001 Nov; 158(3):222-3. PubMed ID: 11713610
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
    Shankar RP; Karan RS; Handu SS; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
    Haas DC; Sheehe PR
    Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hyperkinetic child with dextroamphetamine and ephedrine.
    Scanlon J
    Pediatrics; 1970 Dec; 46(6):975-6. PubMed ID: 5531018
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of D-amphetamine on defensive behaviors related to fear and anxiety.
    Markham CM; Yang M; Blanchard RJ; Blanchard DC
    Pharmacol Biochem Behav; 2006 Apr; 83(4):490-9. PubMed ID: 16624396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
    Whitley HP; Moorman KL
    Pharmacotherapy; 2007 Oct; 27(10):1440-5. PubMed ID: 17896898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole Treatment of Compulsive Behaviors Associated With Methylphenidate in a Child With Down Syndrome.
    Sertdemir M; Akça ÖF
    J Clin Psychopharmacol; 2018 Apr; 38(2):159-161. PubMed ID: 29389777
    [No Abstract]   [Full Text] [Related]  

  • 20. Affective and neuropsychological correlates of children's rituals and compulsive-like behaviors: continuities and discontinuities with obsessive-compulsive disorder.
    Pietrefesa AS; Evans DW
    Brain Cogn; 2007 Oct; 65(1):36-46. PubMed ID: 17630062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.